Exploring the influence of steric, electronic and lipophilic descriptors of 1,3-diarly propenones on their anti-inflammatory activity

DARU, Journal of Pharmaceutical Sciences

Volumn 18, Issue 3, 2010, Pages 230-236

  Bhatia, N M ^a   Mahadik, K R ^b   Bhatia, M S ^a  

^a BHARATI VIDYAPEETH COLLEGE OF PHARMACY   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Anti inflammatory; COX 2; Diarylpropenone; QSAR

Indexed keywords

1,3 DIARLY PROPENONE DERIVATIVE; 1,3 DIARLYPROP 2 EN 1 ONE DERIVATIVE; ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PAW EDEMA; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; TREATMENT RESPONSE;

EID: 78149460405     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Vane J. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biology, 1971; 231: 232-235.
2. Marnett L.J, Kalgutkar A.S Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future. Trends Pharm. Sci., 1999; 20: 465-469.
3. Allison M.C, Howatson A.G, Torrance C.J, Lee F.D, Russel R.I. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. New Engl. J. Med., 1992; 327: 749-754.
4. Zambre A.P, Ganure A.L, Shinde D.B, Kulkarni V.M. Perspective assessment of COX-1 and COX-2 Selectivity of Nonsteroidal Anti-Inflammatory Drugs from Clinical Practice: Use of Genetic Function Approximation. J. Chem. Inf. Model., 2007; 47: 635-643.
5. Fatima A.O, Adel A.E. Synthesis of polyfunctionally substituted heteroaromatic compounds via benzotriazolyl chalcones with antimicrobial and antifungal activities. J. Heterocycl. Chem., 2004; 41: 327-333.
6. Khan M.S.Y, Hasan S.M. Synthesis, antiinflammatory and antibacterial activity of some new flavonoidal derivatives. Indian J. Chem., 2003; 42B: 1970-1974.
7. Lahtchev K.L, Batovska D.I, Parushev S.P, Ubiyvovk V.M, Sibirny A.A. Antifungal activity of chalcones: a mechanistic study using various yeast strains. Eur. J. Med. Chem., 2008; 43: 2220-2228.
8. Sivakumar P.M, Seenivasan P.S, Kumar V, Doble M. Synthesis, antimycobacterial activity evaluation and QSAR studies of chalcone derivatives. Bioorg. Med. Chem. Lett., 2007; 17: 1695-1700.
9. Solankee A, Patel J. Synthesis of chalcones, pyrazolines, aminopyrimidines and pyrimidinethiones as antibacterial agents. Indian J. Chem., 2004; 43B: 1580-1584.
10. Liu M, Wilairat P, Croft S.L, Tan A.L, Go M.L. Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg. Med. Chem., 2003; 11: 2729-2738.
11. Xu Y.C, Leung S.W.S, Yeung D.K.Y, Hu L.H, Chen GH, Che C.M, Man R.Y.K. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery. Phytochem., 2007; 68: 1179-1188.
12. Herencia F, Lopez-Garcia M.P, Ubeda A, Ferrandiz, M.L. Nitric oxide-scavenging properties of some chalcone derivatives. Nitric Oxide, 2002; 6: 242-246.
13. Hasan A, Khan K.M, Sher M, Maharvi G.M, Nawaz S.A, Choudhary M.I, Atta-Ur-Rahman, Supuran CT. Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of some variably substituted chalcones J. Enz. Inh. Med. Chem., 2005; 20: 41-47.
14. Hsieh H.K, Lee T.H, Wang J.P, Wang J.J, Lin C.N. Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm. Res., 1998; 15: 39-46.
15. Herencia F, Ferrandiz, M.L, Ubeda A, Dominguez J.N, Charris J.E, Lobo G.M, Alcaraz M.J. Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg. Med. Chem. Lett., 1998; 8: 1169-1174.
16. De Leon E.J, Alcaraz M.J, Terencio M.C, Dominguez J.N, Charris J. A new chloroquinolinyl chalcone derivative as inhibitor of inflammatory and immune response in mice and rats. J. Pharm. Pharmacol., 2003; 55: 1313-1321.
17. Ostad S.N, Motahhary P, Beshkar M, Ghahremani M.H. 17β-estradiol and progesterone upregulate cyclooxygenase-2 expression in the human gingival fibroblasts. DARU, 2006; 14: 190-196.
18. Foresti R, Hoque M, Monti D, Green C.J, Motterlini R. J. Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. Pharmacol. Exp. Ther., 2005; 312: 686-693.
19. Furniss B.S, Hannaford A.J, Smith P.W.G, Tatchell A.R. Vogel's textbook of practical organic chemistry, New York, ELBS publications. 1988; 5th edn., 1034-1035.
20. Gasull E.I, Silber J.J, Blanco S.E, Tomas F, Ferretti F.H. A theoretical and experimental study of the formation mechanism of 4-X-chalcones by the Claisen-Schmidt reaction. THEOCHEM, 2000; 503: 131-144.
21. Ratheesh M, Helen A. Anti-inflammatory activity of Ruta graveolens Linn on carrageenan induced paw edema in wistar male rats. Afr. J. Biotechnol., 2007; 6: 1209-1211.
22. Vogel G.H, Drug discovery and evaluation: Pharmacological assays, Springer-Verlag Berlin Heidelberg, New York, 2002; 2nd edn., 725-771.
23. Teorell T. Kinetics of distribution of substances administered to the body. I: The extravascular modes of administration. Arch. Int. Pharmacodyn., 1937; 57: 205-225.